Rationale for Combining Radiotherapy and Immune Checkpoint Inhibition for Patients With Hypoxic Tumors

dc.contributor.author	Eckert, Franziska
dc.contributor.author	Zwirner, Kerstin
dc.contributor.author	Böke, Simon
dc.contributor.author	Thorwarth, Daniela
dc.contributor.author	Zips, Daniel
dc.contributor.author	Huber, Stephan
dc.date.accessioned	2020-05-19T07:56:13Z
dc.date.available	2020-05-19T07:56:13Z
dc.date.issued	2019
dc.identifier.issn	1664-3224
dc.identifier.uri	http://hdl.handle.net/10900/100775
dc.language.iso	en	en
dc.publisher	Frontiers Media Sa	de_DE
dc.relation.uri	http://dx.doi.org/10.3389/fimmu.2019.00407
dc.subject.ddc	570	de_DE
dc.subject.ddc	610	de_DE
dc.title	Rationale for Combining Radiotherapy and Immune Checkpoint Inhibition for Patients With Hypoxic Tumors	de_DE
dc.type	Artikel	de_DE
utue.quellen.id	20190926111821_02150
utue.personen.roh	Eckert, Franziska
utue.personen.roh	Zwirner, Kerstin
utue.personen.roh	Boeke, Simon
utue.personen.roh	Thorwarth, Daniela
utue.personen.roh	Zips, Daniel
utue.personen.roh	Huber, Stephan M.
dcterms.isPartOf.ZSTitelID	Frontiers in Immunology	de_DE
dcterms.isPartOf.ZS-Issue	Article 407	de_DE
dcterms.isPartOf.ZS-Volume	10	de_DE
utue.fakultaet	04 Medizinische Fakultät
utue.fakultaet	Sonstige

Files in this item

Files	Size	Format	View
There are no files associated with this item.